Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on Maralixibat Chloride for Treating Itchy Skin in Patients with Cholestatic Pruritus
FranceStudy of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments
AustriaStudy on Nemvaleukin Alfa and Pembrolizumab for Patients with Advanced Skin or Mucosal Melanoma
ItalyStudy on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments
HungaryStudy Comparing High Dose Interferon, Ipilimumab, and Pembrolizumab for Patients with High Risk Resected Melanoma
IrelandStudy on Sonidegib for Patients with Locally Advanced Basal Cell Carcinoma
ItalyStudy on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid
FranceStudy on the Effectiveness of Nintedanib and Tocilizumab for Patients with Systemic Sclerosis and Interstitial Lung Disease
PolandStudy on the Safety and Effectiveness of EHSG-KF for Treating Deep Dermal and Full Thickness Burns in Children
ItalyStudy of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors
CzechiaStudy on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
BulgariaStudy on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis
AustriaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
